Skip to main content
. 2019 Nov 13;5(12):1018–1026. doi: 10.1016/j.jdcr.2019.07.004

Fig 3.

Fig 3

Cytokine measurements in patient 1. In patient 1, plasma was collected during a DIHS flare (Fig 1, June 2017) just prior to (baseline) reinitiation of tofacitinib and then again after 24 hours and 5 days of therapy. Each measurement was performed in duplicate. This analysis was not performed in patient 2. Measurement of cytokines described in the Supplement. *Ref indicates references ranges from ARUP laboratories.